Aaron Keeley

Covalent fragment libraries in drug discovery.

G. Keserű, P. Ábrányi‐Balogh, L. Petri, 2020, Drug discovery today.

Crystallographic and electrophilic fragment screening of the SARS-CoV-2 main protease

James D. Firth, Hanna F. Klein, M. Noble, 2020, Nature Communications.

Activation-Free Sulfonyl Fluoride Probes for Fragment Screening

G. Keserű, Dániel Szabó, P. Ábrányi‐Balogh, 2023, Molecules.

Bromo-Cyclobutenaminones as New Covalent UDP-N-Acetylglucosamine Enolpyruvyl Transferase (MurA) Inhibitors

G. Keserű, P. Ábrányi‐Balogh, I. D. Esch, 2020, Pharmaceuticals.

Next-Generation Heterocyclic Electrophiles as Small-Molecule Covalent MurA Inhibitors

G. Keserű, J. Ilaš, P. Ábrányi‐Balogh, 2022, Pharmaceuticals.

Heterocyclic electrophiles as new MurA inhibitors

G. Keserű, J. Ilaš, P. Ábrányi‐Balogh, 2018, Archiv der Pharmazie.

Design and characterization of a heterocyclic electrophilic fragment library for the discovery of cysteine-targeted covalent inhibitors

G. Keserű, P. Ábrányi‐Balogh, A. Keeley, 2018, MedChemComm.